We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
BSX-PA

Price
-
Stock movement up
+2.83 (2.37%)
Company name
Boston Scientific Corporation
Exchange
(NYSE
,
Currency
USD
)
Sector
Healthcare >
Medical Devices
Market cap
-
Ent value
14.21B
Price/Sales
-
Price/Book
-
Div yield
4.50%
Div growth
-
Growth years
-
FCF payout
4.64%
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
45.11%
1 year return
11.42%
3 year return
3.80%
5 year return
-
10 year return
-
Last updated: 2024-12-17

DIVIDENDS

Dividend yield - 5y

Dividend yield data
Dividend per share5.50
Dividend yield4.50%
Payout frequencyQuarterly
Maximum yield5.60%
Average yield4.88%
Minimum yield4.28%
Discount to avg yield-8.45%
Upside potential-7.79%
Yield as % of max yield80.32%

Yield distribution (inverse percentile) - 5y

Yield distribution data
Dividend yield4.50%
Current yield distribution94.59%
Yield at 100% (Min)4.28%
Yield at 90%4.60%
Yield at 80%4.68%
Yield at 50% (Median)4.85%
Yield at 20%5.10%
Yield at 10%5.22%
Yield at 0% (Max)5.60%

Dividend per share

Dividend per share data
Years of growth-
CCC status-
Dividend per share5.50
Payout frequencyQuarterly
Ex-div date12 May 2023
EPS (TTM)0.62
EPS (1y forward)-
EPS growth (5y)45.11%
EPS growth (5y forward)-

Dividend growth

Please create a free account or log in to access this chart
Dividend growth data
BSX-PAS&P500
DGR MR-4.25%-13.74%
DGR TTM-6.60%
DGR 3 years-5.24%
DGR 5 years-5.40%
DGR 10 years-7.07%
DGR 15 years-6.12%
Time since last change announced1778 days
EPS growth (5y)45.11%
EPS growth (5y forward)-

Payout ratio

Please create a free account or log in to access this chart
Payout ratio data
EPS coverageFCF coverage
TTM6.10%4.64%
Average--
Forward--

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA4.94

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales-
Price to Book-
EV to Sales1.09

FINANCIALS

Per share

Per share data
Current share count-
EPS (TTM)0.62
FCF per share (TTM)0.82

Income statement

Income statement data
Revenue (TTM)13.04B
Gross profit (TTM)8.97B
Operating income (TTM)1.92B
Net income (TTM)902.00M
EPS (TTM)0.62
EPS (1y forward)-

Margins

Margins data
Gross margin (TTM)68.75%
Operating margin (TTM)14.71%
Profit margin (TTM)6.91%

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash570.00M
Net receivables2.08B
Total current assets5.70B
Goodwill13.27B
Intangible assets6.06B
Property, plant and equipment0.00
Total assets32.89B
Accounts payable868.00M
Short/Current long term debt9.37B
Total current liabilities4.08B
Total liabilities14.78B
Shareholder's equity18.11B
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)1.77B
Capital expenditures (TTM)612.00M
Free cash flow (TTM)1.19B
Dividends paid (TTM)55.00M

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity4.98%
Return on Assets2.74%
Return on Invested Capital3.33%
Cash Return on Invested Capital4.37%

STOCK INFORMATION

Downside potential

Downside potential data
BSX-PAS&P500
Current price drop from All-time high-4.82%-12.53%
Highest price drop-23.34%-56.47%
Date of highest drop16 Jun 20229 Mar 2009
Avg drop from high-9.39%-11.07%
Avg time to new high69 days12 days
Max time to new high448 days1805 days
COMPANY DETAILS
BSX-PA (Boston Scientific Corporation) company logo
Marketcap
-
Marketcap category
Small-cap
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, that uses in the treatment of coronary artery disease and aortic valve conditions. Further, it provides stents, balloon catheters, guidewires, atherectomy, and thrombectomy systems to treat arterial and venous diseases; and peripheral embolization devices, radioactive microspheres, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Employees
45000
Website
https://www.bostonscientific.com
Investor relations
-
SEC filings
BSX-PA SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
Quarterly
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved